Vitamin B12 Deficiency: What the Diagnostic Research Covers

Vitamin B12 (cobalamin) deficiency is among the most prevalent micronutrient deficiencies in the UK, yet it is frequently missed in routine clinical assessment. The National Diet and Nutrition Survey (NDNS) — the UK's continuous rolling survey of dietary intake and nutritional status — has documented low B12 biomarker status across multiple population subgroups, with older adults and those following plant-based diets showing the highest rates. A comprehensive analysis of NDNS data estimated that approximately 6% of adults aged 19–64 and up to 20% of those over 65 have serum B12 below the conventional deficiency threshold of 148 pmol/L (200 pg/mL). The elderly are disproportionately affected because gastric acid secretion declines with age, impairing release of protein-bound B12 from food — a distinct mechanism from pernicious anaemia (the classic autoimmune loss of intrinsic factor) that the literature terms 'food-cobalamin malabsorption'. Andrès et al. (2003) characterised this as a syndrome responsible for up to 60% of B12 deficiency in older patients (PMID: 12791608). In vegan and vegetarian populations, the picture is stark. B12 is found almost exclusively in animal-derived foods — meat, fish, dairy, and eggs. Algae and fermented plant foods contain analogues that are biologically unreliable and may even compete with active B12 at receptor sites. A systematic review and meta-analysis published in the European Journal of Clinical Nutrition (2014) reported median serum B12 below the clinical deficiency threshold in approximately 52% of vegans studied across multiple cohorts (PMID: 24667752). The NHS, British Dietetic Association, and SACN all state that vegans require B12 from supplements or fortified foods because dietary sources are absent. Deficiency is frequently under-diagnosed because: 1. Serum B12 has a wide reference range and low specificity — early functional deficiency can exist at serum levels conventionally classified as 'normal'. 2. Neurological symptoms (peripheral neuropathy, subacute combined degeneration of the spinal cord) may present before haematological changes — haemoglobin and MCV remain normal in 28% of patients with neuropsychiatric manifestations of B12 deficiency. 3. GPs in UK primary care are not universally trained to use functional biomarkers such as methylmalonic acid (MMA) or holotranscobalamin (holoTC) that detect deficiency earlier in the biochemical cascade. A 2014 review in the British Journal of Haematology noted that serum B12 assay performance varies between manufacturers by as much as 25%, and cross-laboratory standardisation remains imperfect (PMID: 24580810). These analytical limitations, combined with an ageing population and growing prevalence of plant-based diets, suggest clinically significant under-diagnosis. For context on related B-vitamin interactions, see [folate](/items/folate) and [vitamin B6](/items/vitamin-b6), both of which influence the same one-carbon metabolism pathway.